83
Views
3
CrossRef citations to date
0
Altmetric
Review

Developments in managing severe chronic pain: role of oxycodone–naloxone extended release

&
Pages 3811-3816 | Published online: 22 Jul 2015

References

  • BlythFMMarchLMBrnabicAJJormLRWilliamsonMCousinsMJChronic pain in Australia: a prevalence studyPain2001892–312713411166468
  • JohannesCBLeTKZhouXJohnstonJADworkinRHThe prevalence of chronic pain in United States adults: results of an Internet-based surveyJ Pain201011111230123920797916
  • ToblinRLMackKAPerveenGPaulozziLJA population-based survey of chronic pain and its treatment with prescription drugsPain201115261249125521397401
  • VetterTRA primer on he prevalence of pain in patients with cancer: a systematic review of the past 40 years alth-related quality of life in chronic pain medicineAnesth Analg2007104370371817312232
  • BreivikHCollettBVentafriddaVCohenRGallacherDSurvey of chronic pain in Europe: prevalence, impact on daily life, and treatmentEur J Pain20061028733316095934
  • RipamontiCISantiniDMaranzanoEBertiMRoilaFManagement of cancer pain: ESMO clinical practice guidelinesAnn Oncol20127139154
  • van den Beuken-van EverdingenMHde RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol20071891437144917355955
  • HootenWTimmingRBelgradeMAssessment and Management of Chronic PainBloomington: MNInstitute for Clinical Systems Improvement2013
  • TerwindtGFerrariMDTijhuisMGroenenSMPicavetHSLaunerLJThe impact of headache on quality of life in the general population: the GEM studyNeurology200055562462910980723
  • GrimbyARosenhallUHealth-related quality of life and dizziness in old ageGerontology1995412862988537013
  • FlechtnerHBottomleyAFatigue and quality of life: lessons from the real worldOncologist20038suppl 15912626781
  • PanchalSJMuller-SchwefePWurzelmannJIOpioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInt J Clin Pract2007611181118717488292
  • HolzerPAhmedzaiSHNiederleNOpioid-induced bowel dysfunction in cancer related pain: causes, consequences, and a novel approach for its managementJ Opioid Manag20095314515119662924
  • PappagalloMIncidence, prevalence, and management of opioid bowel dysfunctionAm J Surg200118211S18S11755892
  • AhmedzaiSHBolandJConstipation in people prescribed opioidsBMJ Clin Evid201062010
  • KumarLBarkerCEmmanuelAOpioid-induced constipation: pathophysiology, clinical consequences, and managementGastroen-terol Res Pract20142014141737
  • CamilleriMOpioid-induced constipation: challenges and therapeutic opportunitiesAm J Gastroenterol2011106583584221343919
  • ChoiYSBillingsJAOpioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipationJ Pain Symptom Manage2002241719012183097
  • RileyJEisenbergEMüller-SchwefeGDrewesAMArendt-NielsenLOxycodone: a review of its use in the management of painCurr Med Res Opin20082417519218039433
  • MercadanteSGiarratanoACombined oral prolonged- release oxy-codone and naloxone in chronic pain managementExpert Opin Investig Drugs201322161166
  • de Leon-CasasolaOAOpioids for chronic pain: new evidence, new strategies, safe prescribingAm J Med20131263 suppl 1S3S1123414718
  • American Society of Anesthesiologists Task Force on Chronic Pain ManagementAmerican Society of Regional Anesthesia and Pain MedicinePractice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain MedicineAnesthesiology2010112481083320124882
  • FranklinGMOpioids for chronic noncancer pain: a position paper of the American Academy of NeurologyNeurology201483141277128425267983
  • BellTAnnunziataKLeslieJBOpioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness SurveyJ Opioid Manag2009513714419662923
  • BellTJPanchalSJMiaskowskiCBolgeSCMilanovaTWilliamsonRThe prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE1)Pain Med200910354218721170
  • ClemensKEQuednauIKlaschikEBowel function during pain therapy with oxycodone/naloxone prolonged-release tablets in patients with advanced cancerInt J Clin Pract201165447247821401835
  • DennisonCPrasadMLloydABhattacharyyaSKDhawanRCoyneKThe health-related quality of life and economic burden of constipationPharmacoeconomics200523546147615896098
  • RentzAMYuRMüller-LissnerSLeyendeckerPValidation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipationJ Med Econ200912437138319912069
  • RentzAMvan Hanswijck de JongePLeyendeckerPHoppMObservational, nonintervention, multi center study for validation of the Bowel Function Index for constipation in European countriesCurr Med Res Opin2011271354421083515
  • CoffinBCausseCConstipation assessment scales in adults: a literature review including the new Bowel Function IndexExpert Rev Gastroenterol Hepatol20115560161321910578
  • UeberallMAMüller-LissnerSBuschmann-KrammCBosseBThe Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patientsJ Int Med Res2011391415021672306
  • DucrottePCausseCThe Bowel Function Index: a new validated scale for assessing opioid-induced constipationCurr Med Res Opin201228345746622236136
  • TamayoACDiaz-ZuluagaPAManagement of opioid-induced bowel dysfunction in cancer patientsSupport Care Cancer200412961361815221581
  • HolzerPNon-analgesic effects of opioids: Mangement of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?Curr Pharmaceutical Design20121860106020
  • TackJCurrent and future therapies for chronic constipationBest Pract Res Clin Gastroenterol201125115115821382586
  • BenyaminRTrescotAMDattaSOpioid complications and side effectsPain Physician2008112S105S12018443635
  • HolzerPOpioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humansNeurosci Lett20043611–319219515135926
  • PoulsenJLBrockCOlesenAENilssonMDrewesAMClinical potential of naloxegol in the management of opioid-induced bowel dysfunctionClin Exp Gastroenterol2014734535825278772
  • BaderSDurkTBeckerGMethylnaltrexone for the treatment of opioid-induced constipationExpert Rev Gastroenterol Hepatol201371132623265145
  • LeppertWEmerging therapies for patients with symptoms of opioid-induced bowel dysfunctionDrug Des Devel Ther2015922152231
  • LeonardJBakerDENaloxegol: treatment for opioid-induced constipation in chronic non-cancer painAnn Pharmacother201549336036525471070
  • SmithKHoppMMundinGLow absolute bioavailability of oral naloxone in healthy subjectsInt J Clin Pharmacol Ther201250536036722541841
  • LöwensteinOLeyendeckerPLuxEAEfficacy and safety of combined prolonged release oxycodone and naloxone in the management of moderate/severe chronic non-malignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trialsBMC Clin Pharmacol2010101220920236
  • VondrackovaDLeyendeckerPMeissnerWAnalgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic painJ Pain20089121144115418708300
  • SimpsonKLeyendeckerPHoppMFixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer painCurr Med Res Opin200824123503351219032132
  • LöwensteinOLeyendeckerPHoppMCombined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trialExpert Opin Pharmacother200910453154319243306
  • PoelaertJKoopmans-KleinGDiohATreatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipationClin Ther201537478479225757607
  • VosTFlaxmanADNaghaviMLozanoRMichaudCYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet20123802163219623245607
  • ChouRQaseemASnowVClinical Efficacy Assessment Subcommittee of the American College of PhysiciansAmerican College of PhysiciansAmerican Pain Society Low Back Pain Guidelines PanelDiagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain SocietyAnn Intern Med200714747849117909209
  • ZhangWDohertyMArdenNEULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Ann Rheum Dis20056466968115471891
  • JordanKMArdenNKDohertyMStanding Committee for International Clinical Studies Including Therapeutic Trials ESCISITEULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Ann Rheum Dis2003621145115514644851
  • HochbergMCAltmanRDAprilKTAmerican College of Rheu-matologyAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care Res201264465474
  • McAlindonTEBannuruRRSullivanMCOARSI guidelines for the non-surgical management of knee osteoarthritisOsteoarthritis Cartilage20142236338824462672
  • MachadoGCMaherCGFerreiraPHEfficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trialsBMJ2015350h122525828856
  • National Institute for Health and Care ExcellenceOsteoarthritis: Care and Management in AdultsNICE2014 Available from: www.nice.org.uk/guidance/cg177
  • MallenCHayEManaging back pain and osteoarthritis without paracetamolBMJ2015350h135225828857
  • CheungCWQiuQChoiSWMooreBGouckeRIrwinMChronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelinesPain Physician201417540141425247898
  • BlagdenMHaferJDuerrHHoppMBosseBLong-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trialsNeurogastroenterol Motil201426121792180125346155
  • DavisMPSrivastavaMDemographics, assessment and management of pain in the elderlyDrugs Aging2003201235712513114
  • GibsonSJLussierDPrevalence and relevance of pain in older personsPain Med201213suppl 2S23S2622497744
  • ChaiEHortonJRManaging pain in the elderly population: pearls and pitfallsCurr Pain Headache Rep201014640941720878270
  • AbdullaABoneMAdamsNEvidence-based clinical practice guidelines on management of pain in older peopleAge Ageing201342215115323335785
  • GuerrieroFSgarlataCMarcassaCRicevutiGRolloneMEfficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patientsClin Interv Aging201410111.3125565782
  • ChapmanSLByas-SmithMGReedBAEffects of intermediate- and long-term use of opioids on cognition in patients with chronic painClin J Pain200218suppl 4S83S9012479258
  • KambojSKTookmanAJonesLCurranHVThe effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative carePain2005117338839516198201
  • TassainVAttalNFletcherDLong term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer painPain20031041–238940012855350